CDSCO UID IMP/IVD/2023/000051_e345189c61147d5beece1f71ab4abb73_8a0b65ead58db7c639a786afdf74a91d
LDL-CHOLESTEROL Direct Method
Wheecon Instruments Private Limited·Device Class Class B·India CDSCO·Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Registration details
- UID
- IMP/IVD/2023/000051_e345189c61147d5beece1f71ab4abb73_8a0b65ead58db7c639a786afdf74a91d
- Device class
- Class B
- Brand name
- BIOLABO ACID CALCIUM Arsenazo III Method
- License holder
- Wheecon Instruments Private Limited
- Approving authority
- CDSCO
- Product information
- Low density lipoproteins (BIOLABO ACID CALCIUM Arsenazo III Method), are synthesized in the liver by the action of various lipolytic enzymes on triglycerides rich very low density lipoproteins (BIOLABO ACID CALCIUM Arsenazo III Method). Many epidemiological and clinical studies have shown that an increased LDL-Cholesterol is associated with increased risk of atherosclerosis and coronary artery disease (BIOLABO ACID CALCIUM Arsenazo III Method). Some studies showed that a reduction in LDL-Cholesterol is correlated with regression in atherosclerotic lesion
Similar products (10)
Other products with the same name or brand
IRON Bathophenanthrolin(BIOLABO IRON Bathophenanthrolin)
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
LIPASE Kinetic Method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
MAGNESIUM Calmagite
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
MICROALBUMIN Turbidimetric Immunoassay
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
ALT GPT Colorimetric Method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
STONE ANALYSIS SET Chemical qualitative method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
URIC ACID Uricase method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
UREA U.V Kinetic Method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
TOTAL AND DIRECT BILIRUBIN Sulfanilic Acid Method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
HDL-CHOLESTEROL Precipitant(BIOLABO HDL-CHOLESTEROL Precipitant)
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Wheecon Instruments Private Limited
Class B
Other products from Wheecon Instruments Private Limited
Products from the same license holder (10 products)
URYXXON 500
Brand: URYXXON 500
Class A
URYXXON Relax
Brand: URYXXON 500
Class A
IRON Bathophenanthrolin(BIOLABO IRON Bathophenanthrolin)
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Class B
LIPASE Kinetic Method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Class B
MAGNESIUM Calmagite
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Class B
MICROALBUMIN Turbidimetric Immunoassay
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Class B
ALT GPT Colorimetric Method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Class B
STONE ANALYSIS SET Chemical qualitative method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Class B
URIC ACID Uricase method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Class B
UREA U.V Kinetic Method
Brand: BIOLABO ACID CALCIUM Arsenazo III Method
Class B
About this record
LDL-CHOLESTEROL Direct Method is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000051_e345189c61147d5beece1f71ab4abb73_8a0b65ead58db7c639a786afdf74a91d. This device is marketed under the brand name BIOLABO ACID CALCIUM Arsenazo III Method. The license holder is Wheecon Instruments Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.